NHC

National Healthcare Corp Health Care Services-Skilled Nursing Care Facilities Russell 3000
$206.14Close $3.2BMarket cap $118.03 – $247.9452-week range Nov 6, 2026Next report

Highlights

Strengths

  • Leading the market RS 80 · stronger than 80% of stocks over 12 months
  • Earnings growing EPS +67% year on year, faster than the quarter before (+57 pts)

Cautions

  • Trend not confirmed 7 of 8 conditions · under the 50-day
  • Distribution down-day volume 1.6× up-day volume over 50 sessions
  • Results soon Nov 6, 2026, in 5 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 17%
1wk down 12.7% price change
1mo down 6.1% price change
12-month return up 71% market up 11% · its own up 62%
F-score — — Not assessed
Altman Z″ 5.72 Low risk
P/E 26.7× price / earnings
PEG 1.53 P/E / EPS growth
P/B 3.0× price / book
Earnings yield up 4.1% EBIT / enterprise value
Cheaper than 58% of the market · around average
Revenue growth up 16% year on year
EPS growth up 67% latest quarter · +57 pts
Sales growth up 9% latest quarter · +7 pts
ROE up 12% return on equity
Free cash margin up 10% $148.6M FCF
D/E 0.03 long-term debt / equity
Net debt / EBITDA -0.3× net cash
Interest cover —EBIT / interest
Piotroski tests

Repair signals

  • Long-term debt down 75% ($0.1B → $0.0B)

Trade setup

ATR% 4.2% $8.59 a day · 2×ATR $188.96
RS 80 / 99 vs the universe
Trend 7 / 8 under the 50-day
Relative volume 1.2× vs 50-day average
Up/down volume 0.64 50 sessions
Implied move — no option chain · report Nov 6, 2026
Trend template · 7 of 8
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 11, 2026
Results reaction Aug 11, 20260% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.5B +16% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.0B FY2021 · $1.1B FY2022 · $1.1B FY2023 · $1.1B FY2024 · $1.3B FY2025 · $1.5B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $120.0M +18% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $41.9M FY2021 · $138.6M FY2022 · $22.4M FY2023 · $66.8M FY2024 · $101.9M FY2025 · $120.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $148.6M +86% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $181.4M FY2021 · $23.0M FY2022 · -$21.5M FY2023 · $83.3M FY2024 · $79.7M FY2025 · $148.6M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 8%
  • Free cash 10%
0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 4% · Free cash 18% FY2021 · Net 13% · Free cash 2% FY2022 · Net 2% · Free cash -2% FY2023 · Net 6% · Free cash 7% FY2024 · Net 8% · Free cash 6% FY2025 · Net 8% · Free cash 10%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $60.3M net cash
  • Cash
  • Long-term debt
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $147.1M FY2021 · Cash $107.6M FY2022 · Cash $58.7M FY2023 · Cash $107.1M · Long-term debt $0 FY2024 · Cash $76.1M · Long-term debt $129.5M FY2025 · Cash $92.8M · Long-term debt $32.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 15.54m +1.1% since FY2020
15.54m 15.35m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 15.37m FY2021 · 15.45m FY2022 · 15.36m FY2023 · 15.35m FY2024 · 15.45m FY2025 · 15.54m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.0B $1.1B $1.1B $1.1B $1.3B $1.5B
Operating income $48.2M $50.9M $31.9M $57.5M $89.9M $128.4M
Net income $41.9M $138.6M $22.4M $66.8M $101.9M $120.0M
Net margin 4% 13% 2% 6% 8% 8%
Earnings per share $2.72 $8.99 $1.45 $4.34 $6.53 $7.67
Free cash flow $181.4M $23.0M -$21.5M $83.3M $79.7M $148.6M
Free cash margin 18% 2% -2% 7% 6% 10%
Cash $147.1M $107.6M $58.7M $107.1M $76.1M $92.8M
Long-term debt — — — $0 $129.5M $32.5M
Shareholders' equity $795.2M $903.0M $874.3M $908.8M $980.2M $1.1B
Shares outstanding 15.37m 15.45m 15.36m 15.35m 15.45m 15.54m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Feb 16, 2024 Annual ↗ Dec 31, 2023 47d
Nov 2, 2023 Quarterly ↗ Sep 30, 2023 33d

Current reports